Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

GEHC vs VEEV: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

VEEV Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 7–3 Matrix Metrics)

VEEV Overall Winner 6-Pillar Tally: GEHC 2 – 4 VEEV Matrix Metrics: GEHC 3 – 7 VEEV

As of Nov 17, 2026, Veeva Systems Inc. (VEEV) is the stronger overall head-to-head candidate over GE HealthCare Technologies Inc. (GEHC) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). GEHC carries a Unified Composite Score of 38.8/100 (SELL) at $82.22 (15.1x Forward P/E, 13.8% operating margin), whereas VEEV carries 48.5/100 (HOLD) at $290.25 (34.8x Forward P/E, 29.9% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About GEHC vs VEEV
GEHC NASDAQ
GE HealthCare Technologies Inc. Common Stock
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
$82.22
-0.89% 1D
Market Cap $37.5B
TTM Revenue $21.6B
Forward P/E 15.1x
Beta / 30D Vol 0.54β · 38% Vol
Unified Composite Score
38.8 / 100 SELL
Tech 25.0 Fund 40.0 Flow 58.0 Mom 40.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (3.9% over 20 days), RSI 66
RSI-14: 66.0 · SMA20: $78.83 · SMA50: $71.15
VEEV NYSE Head-to-Head Winner
Veeva Systems Inc.
Services-Prepackaged Software
$290.25
-3.02% 1D
Market Cap $48.8B
TTM Revenue $3.46B
Forward P/E 34.8x
Beta / 30D Vol 0.39β · 20% Vol
Unified Composite Score
48.5 / 100 HOLD
Tech 45.0 Fund 53.0 Flow 68.0 Mom 46.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 41
RSI-14: 40.9 · SMA20: $309.35 · SMA50: $292.48

6-Pillar Scorecard Institutional Category Breakdown (GEHC 2 – 4 VEEV)

Columns: Metric · GEHC · VEEV
1. Valuation Multiples GEHC
Forward P/E 15.1x 34.8x
Trailing P/E 17.6x 49.4x
PEG Ratio 2.22x 1.16x
EV / Revenue 2.1x 13.6x
2. Growth & Scale VEEV
Revenue Growth (YoY) +7.2% +17.6%
Earnings Growth (YoY) +39.0% +39.5%
TTM Revenue (USD) $21.6B $3.46B
Market Cap $37.5B $48.8B
3. Profitability & Quality VEEV
Gross Margin 39.3% 75.0%
Operating Margin 13.8% 29.9%
Net Profit Margin 10.0% 29.3%
Return on Equity (ROE) 20.0% 14.4%
4. Balance Sheet & Cash Flow VEEV
Cash Generation (TTM) $1.89B $1.67B
Cash Flow Margin 8.7% 48.2%
Net Cash / Leverage $7.58B Net Debt (0.90x D/E) $1.66B Net Cash
Dividend Yield 0.18% None (0.00%)
5. Options & Positioning GEHC
Options Structure Phase SURGE CONSOLIDATION
Current IV / %ile 32.3% (3rd %ile) 45.0% (55th %ile)
Put/Call OI Skew 0.22x (Call-Skewed) 0.71x (Call-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Markup DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat VEEV
OpEx & R&D Intensity 25.5% of Rev ($5.52B) 45.1% of Rev ($1.56B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role Medical Devices Operator Health Information Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: GEHC (3) vs VEEV (7)
Institutional Metric GEHC VEEV Criterion Row Edge
Market Capitalization
Scale
$37.5B $48.8B Larger Scale VEEV
Trailing P/E Ratio
Valuation
17.6x 49.4x Lower Multiple GEHC
Forward P/E Ratio
Valuation
15.1x 34.8x Lower Multiple GEHC
Revenue Growth (YoY)
Growth
+7.2% +17.6% Higher Growth VEEV
Operating Margin (TTM)
Profitability
13.8% 29.9% Higher Margin VEEV
Net Profit Margin
Profitability
10.0% 29.3% Higher Margin VEEV
Return on Equity (ROE)
Capital Efficiency
20.0% 14.4% Higher ROE GEHC
52-Week Range Position
Momentum
76% ($59–$90) 80% ($148–$326) Stronger Trend VEEV
Beta / 30D Volatility
Risk Regime
0.54β · 38% Vol 0.39β · 20% Vol Lower Realized Risk VEEV
Unified Institutional Score
Composite Signal
38.8 / 100 (SELL) 48.5 / 100 (HOLD) Higher Composite VEEV
Trailing 12M Revenue (USD)
Operating Scale
$21.6B $3.46B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
39.3% 75.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
2.22x PEG · 2.1x EV/Rev 1.16x PEG · 13.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$1.89B ($7.58B Net Debt (0.90x D/E)) $1.67B ($1.66B Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon GEHC +26.24 pp
GEHC: +17.86% · VEEV: -8.38%
3M Horizon VEEV +5.46 pp
GEHC: +10.18% · VEEV: +15.64%
6M Horizon VEEV +44.21 pp
GEHC: +33.52% · VEEV: +77.73%
1Y Horizon GEHC +13.46 pp
GEHC: +12.4% · VEEV: -1.06%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period GEHC Revenue VEEV Revenue GEHC Op. Margin VEEV Op. Margin Margin Leader
FY2019 N/A $860M N/A 25.8% VEEV
FY2020 N/A $1.10B N/A 25.9% VEEV
FY2021 $17.6B $1.47B 15.9% 25.8% VEEV
FY2022 $18.3B $1.85B 13.8% 27.3% VEEV
FY2023 $19.6B $2.16B 12.5% 21.3% VEEV
FY2024 $19.7B $2.36B 13.3% 18.2% VEEV
FY2025 $20.6B $2.75B 13.4% 25.2% VEEV
FY2026 N/A $3.20B N/A 28.7% VEEV

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
GEHC SURGE
9d in phase · OBV DISTRIBUTION
Current IV 32.3%
IV Percentile 3rd %ile
Put/Call OI Skew 0.22x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact GEHC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
VEEV CONSOLIDATION
55d in phase · OBV DISTRIBUTION
Current IV 45.0%
IV Percentile 55th %ile
Put/Call OI Skew 0.71x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact VEEV Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $82.96 · IV 29.7%

GEHC vs. VEEV: Simulated 5-Day Option Payoffs & Capital Efficiency

Compare 100 shares of GEHC ($8,296) vs. VEEV ($29,928) against risk-defined 5-day vertical and put-wall option structures.

GEHC Spot $82.96 · IV 29.7%
GEHC Options Simulator →
5-DAY BULLISH SWING Liq B

Dec 18 $82.5 / $87.5 Bull Call Spread

Buy 1x $82.5C · Sell 1x $87.5C · 32d

Net Entry $222 Debit
T+5d @ +5% Move +$109 (+49%)
Max Risk / Buffer $222 Capped
5d Edge & Liquidity 0.8x R:R · Liq B
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq B

Dec 18 $77.5 / $72.5 Bull Put Spread

Sell 1x $77.5P · Buy 1x $72.5P · 32d

Net Entry $87 Credit
Max Credit / Yield +$87 (+21.1% RoM)
Max Risk / Buffer -7.6% Cushion ($413 Mgn)
5d Edge & Liquidity 78% PoP · Liq B
Simulate 5-Day Payoff →
VEEV Spot $299.28 · IV 50.8%
VEEV Options Simulator →
5-DAY BULLISH SWING Liq B

Dec 18 $300 / $330 Bull Call Spread

Buy 1x $300C · Sell 1x $330C · 32d

Net Entry $1,140 Debit
T+5d @ +5% Move +$352 (+31%)
Max Risk / Buffer $1,140 Capped
5d Edge & Liquidity 0.8x R:R · Liq B
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq B

Dec 18 $280 / $260 Bull Put Spread

Sell 1x $280P · Buy 1x $260P · 32d

Net Entry $478 Credit
Max Credit / Yield +$478 (+31.4% RoM)
Max Risk / Buffer -8.0% Cushion ($1,522 Mgn)
5d Edge & Liquidity 71% PoP · Liq B
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
GEHC Moat Profile Scale & Operating Efficiency Moat
Medical Devices Operator
Competes within the Medical Devices value chain with $37.5B market capitalization and 13.8% operating margin.
OpEx & R&D Reinvestment 25.5% of Rev ($5.52B)
90D Engineering Disclosures 0 Published
VEEV Moat Profile Scale & Operating Efficiency Moat
Health Information Services Operator
Competes within the Health Information Services value chain with $48.8B market capitalization and 29.9% operating margin.
OpEx & R&D Reinvestment 45.1% of Rev ($1.56B)
90D Engineering Disclosures 0 Published

Investor FAQ GEHC vs VEEV Key Questions & Quantitative Answers

As of Nov 17, 2026, Veeva Systems Inc. (VEEV) is the stronger overall head-to-head candidate over GE HealthCare Technologies Inc. (GEHC) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). GEHC carries a Unified Composite Score of 38.8/100 (SELL) at $82.22 (15.1x Forward P/E, 13.8% operating margin), whereas VEEV carries 48.5/100 (HOLD) at $290.25 (34.8x Forward P/E, 29.9% operating margin). Technically, GEHC sits in a Markup phase (RSI 66.0, SURGE options structure) and VEEV sits in a Neutral phase (RSI 40.9, CONSOLIDATION options structure).

VEEV leads the Growth & Scale pillar: GEHC posts +7.2% YoY revenue growth and +39.0% YoY earnings growth on $21.6B TTM revenue (39.3% gross margin, 13.8% operating margin), compared with VEEV at +17.6% YoY revenue growth and +39.5% YoY earnings growth on $3.46B TTM revenue (75.0% gross margin, 29.9% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), GEHC cumulative revenue shifted +17.2% while VEEV shifted +272.1%. In operating R&D and SG&A reinvestment, GEHC deploys 25.5% of Rev ($5.52B) (0 90-day corporate R&D disclosures) versus 45.1% of Rev ($1.56B) (0 disclosures) for VEEV.

GEHC screens cheaper on headline valuation multiples. GEHC trades at 15.1x Forward P/E, 17.6x Trailing P/E, 2.22x PEG, and 2.1x EV/Revenue (8.7% FCF margin), whereas VEEV trades at 34.8x Forward P/E, 49.4x Trailing P/E, 1.16x PEG, and 13.6x EV/Revenue (48.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GEHC (20.0% ROE) versus VEEV (14.4% ROE) capital efficiency.

In options market volatility and institutional positioning, GEHC carries 32.3% implied volatility (3rd %ile, Compressed (<25th %ile)), a 0.22x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a SURGE options structure phase (0.54β · 38% Vol realized risk). By comparison, VEEV carries 45.0% implied volatility (55th %ile, Balanced (25th–60th %ile)), a 0.71x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.39β · 20% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.